Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma-Reference-Cited by-同舟云学术

Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma

Published:2020-08-08 Issue:2 Volume:184 Page:277-285
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Akashi Momoko,Yamaguchi Rin^ORCID,Kusano Hironori,Ogasawara Sachiko,Abe Eiji,Obara Hitoshi,Yamaguchi Miki,Akiba Jun,Kakuma Tatsuyuki,Tanaka Maki,Akagi Yoshito,Yano Hirohisa

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-020-05855-4.pdf

Reference25 articles.

1. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752. https://doi.org/10.1038/35021093

2. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874. https://doi.org/10.1073/pnas.191367098

3. Curigliano G, Burstein HJ, P Winer E, Gnant M et al (2017) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol 28:1700–1712

4. Dawood S, Broglio K, Buzdar AU et al (2010) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28:92–98. https://doi.org/10.1200/jco.2008.19.9844

5. Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423. https://doi.org/10.1073/pnas.0932692100

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Clinico-Pathological Relationship Between Stromal Tumor-Infiltrating Lymphocytes and Androgen Receptor Expression Across Molecular Subtypes of Invasive Breast Carcinoma;Indian Journal of Surgical Oncology;2024-06-27

2. Research Progress on Prognostic Indicators of Neoadjuvant Therapy for HER-2 Positive Breast Cancer;Advances in Clinical Medicine;2024

3. Apocrine lesions of breast and invasive carcinoma with apocrine differentiation: a brief review;Surgical and Experimental Pathology;2023-11-10

4. Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy;Discover Oncology;2023-04-26

5. Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy;Cancer Research and Treatment;2023-04-15